NEXENTIS TECHNOLOGIES INC. Proceeds from Secured Notes Payable
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Proceeds from Secured Notes Payable of $274.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromSecuredNotesPayable · last filed 2021-11-15
- NEXENTIS TECHNOLOGIES INC. proceeds from secured notes payable for the quarter ending 2021-09-30 was $0.00.
- NEXENTIS TECHNOLOGIES INC. proceeds from secured notes payable for the quarter ending 2021-06-30 was $0.00.
- NEXENTIS TECHNOLOGIES INC. proceeds from secured notes payable for the quarter ending 2021-03-31 was $274.00K, a 102.96% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. proceeds from secured notes payable for the quarter ending 2020-12-31 was $0.00.
- NEXENTIS TECHNOLOGIES INC. proceeds from secured notes payable for fiscal 2020 was $135.00K.
| Period end | Proceeds from Secured Notes Payable 3 month | Proceeds from Secured Notes Payable 6 month | Proceeds from Secured Notes Payable 9 month | Proceeds from Secured Notes Payable 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $274.00K 10-Q · filed 2021-11-15 | $274.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $274.00K 10-Q · filed 2021-08-16 | $274.00K derived: sum of 3 quarters · filed 2021-08-16 | $274.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-03-31 | $274.00K 10-Q · filed 2021-05-18 | $274.00K derived: sum of 2 quarters · filed 2021-05-18 | $274.00K derived: sum of 3 quarters · filed 2021-11-15 | $274.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 derived: sum of 3 quarters · filed 2021-11-15 | $135.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $135.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $135.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $135.00K 10-Q · filed 2021-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |